(0.27%) 5 113.65 points
(0.37%) 38 383 points
(0.36%) 15 985 points
(-1.59%) $82.52
(4.94%) $2.02
(0.22%) $2 352.40
(0.24%) $27.60
(4.16%) $960.50
(-0.21%) $0.933
(-0.37%) $10.98
(-0.53%) $0.796
(1.68%) $93.41
-0.01% $ 1.420
Live Chart Being Loaded With Signals
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States...
Stats | |
---|---|
Tagesvolumen | 1 760.00 |
Durchschnittsvolumen | 33 719.00 |
Marktkapitalisierung | 24.47M |
EPS | $0 ( 2024-03-18 ) |
Nächstes Ertragsdatum | ( $-0.400 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.060 |
ATR14 | $0.0120 (0.85%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-04 | Adawi Kamal | Sell | 9 297 | Common Stock |
2024-03-04 | Adawi Kamal | Sell | 3 487 | Common Stock |
2024-02-29 | Aballi John | Buy | 9 804 | Common Stock |
2024-02-20 | Adawi Kamal | Buy | 75 000 | Common Stock |
2024-02-20 | Aballi John | Buy | 175 000 | Common Stock |
INSIDER POWER |
---|
81.52 |
Last 95 transactions |
Buy: 1 620 208 | Sell: 654 239 |
Exagen Inc Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Exagen Inc Finanzdaten
Annual | 2023 |
Umsatz: | $52.55M |
Bruttogewinn: | $29.46M (56.06 %) |
EPS: | $-1.340 |
FY | 2023 |
Umsatz: | $52.55M |
Bruttogewinn: | $29.46M (56.06 %) |
EPS: | $-1.340 |
FY | 2022 |
Umsatz: | $45.56M |
Bruttogewinn: | $21.35M (46.86 %) |
EPS: | $-2.77 |
FY | 2021 |
Umsatz: | $48.30M |
Bruttogewinn: | $27.71M (57.37 %) |
EPS: | $-1.680 |
Financial Reports:
No articles found.
Exagen Inc
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody and associated vasculitis; AVISE Anti-CarP test, which identifies RA patients with severe disease; and AVISE PC4d to measure platelet- bound C4d. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.